| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
54,235 |
49,188 |
$11.52M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
33,974 |
30,634 |
$10.18M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
14,675 |
13,614 |
$8.56M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
40,302 |
37,713 |
$6.48M |
| G0378 |
Hospital observation service, per hour |
26,691 |
13,201 |
$4.68M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
55,835 |
53,142 |
$2.44M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
20,134 |
15,760 |
$2.32M |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
36,068 |
33,880 |
$2.02M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
4,728 |
4,375 |
$1.90M |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
4,985 |
4,634 |
$1.44M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
16,825 |
13,312 |
$1.40M |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
11,214 |
9,415 |
$1.38M |
| 72125 |
Computed tomography, cervical spine; without contrast material |
5,822 |
5,377 |
$1.31M |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,666 |
3,326 |
$1.25M |
| 70450 |
Computed tomography, head or brain; without contrast material |
17,075 |
15,620 |
$1.22M |
| 70498 |
|
2,352 |
2,181 |
$904K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15,433 |
14,578 |
$848K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
10,254 |
9,943 |
$675K |
| 47562 |
|
165 |
155 |
$567K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
10,433 |
10,073 |
$535K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
32,044 |
25,788 |
$502K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,209 |
4,909 |
$501K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
426 |
401 |
$416K |
| 93458 |
|
324 |
301 |
$394K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
18,324 |
16,821 |
$346K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
1,839 |
1,804 |
$335K |
| 72131 |
|
2,499 |
2,301 |
$310K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,867 |
2,627 |
$306K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,930 |
9,300 |
$296K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
5,070 |
1,512 |
$289K |
| 12001 |
|
1,506 |
1,435 |
$267K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
11,418 |
10,702 |
$266K |
| 70486 |
|
2,207 |
2,071 |
$252K |
| 93970 |
|
1,305 |
1,220 |
$247K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
392 |
364 |
$213K |
| 73610 |
|
3,113 |
2,886 |
$197K |
| 71046 |
Radiologic examination, chest; 2 views |
15,073 |
14,238 |
$194K |
| 74174 |
|
279 |
260 |
$187K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
3,550 |
2,379 |
$186K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
1,447 |
616 |
$186K |
| 80053 |
Comprehensive metabolic panel |
89,567 |
69,894 |
$175K |
| 70496 |
|
2,230 |
2,054 |
$168K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
140 |
128 |
$168K |
| 73562 |
|
2,720 |
2,387 |
$163K |
| 73630 |
|
3,688 |
3,437 |
$154K |
| 73130 |
|
3,001 |
2,772 |
$137K |
| 99201 |
|
1,252 |
1,208 |
$130K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
9,581 |
5,674 |
$124K |
| 93971 |
|
2,855 |
2,673 |
$118K |
| 12011 |
|
745 |
710 |
$102K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
3,263 |
2,988 |
$96K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,132 |
1,089 |
$91K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
20,591 |
15,717 |
$91K |
| 81513 |
|
389 |
370 |
$90K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,777 |
1,706 |
$75K |
| 12002 |
|
545 |
517 |
$74K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
1,612 |
1,453 |
$67K |
| 10060 |
|
567 |
536 |
$63K |
| 84702 |
|
5,810 |
5,230 |
$57K |
| 70491 |
|
128 |
126 |
$50K |
| 97597 |
|
1,418 |
658 |
$46K |
| 58558 |
|
29 |
29 |
$45K |
| 73110 |
|
2,178 |
2,012 |
$44K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
1,033 |
922 |
$42K |
| 59025 |
Fetal non-stress test |
10,621 |
7,658 |
$41K |
| 73564 |
|
533 |
482 |
$40K |
| 49083 |
|
144 |
88 |
$38K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
229 |
213 |
$35K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
556 |
522 |
$34K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,399 |
754 |
$33K |
| 36430 |
|
547 |
427 |
$33K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
2,180 |
1,796 |
$31K |
| 75574 |
|
488 |
461 |
$30K |
| 87070 |
|
2,029 |
1,784 |
$29K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
44,857 |
38,932 |
$28K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
8,363 |
6,461 |
$28K |
| 72141 |
|
159 |
145 |
$27K |
| 72128 |
|
1,831 |
1,688 |
$26K |
| 73030 |
|
2,628 |
2,421 |
$25K |
| G0381 |
Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
1,773 |
1,441 |
$25K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
38,895 |
34,741 |
$24K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
3,813 |
3,638 |
$22K |
| 29125 |
|
278 |
261 |
$22K |
| 97162 |
|
3,056 |
2,727 |
$20K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
2,222 |
2,032 |
$20K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
4,399 |
4,129 |
$19K |
| 74018 |
|
1,089 |
994 |
$19K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,837 |
3,616 |
$18K |
| 73140 |
|
846 |
820 |
$17K |
| 86923 |
|
247 |
195 |
$16K |
| J3490 |
Unclassified drugs |
67,882 |
31,929 |
$16K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
5,243 |
4,534 |
$16K |
| 87507 |
|
166 |
153 |
$15K |
| 86635 |
|
667 |
527 |
$14K |
| 71250 |
|
533 |
505 |
$13K |
| 93976 |
|
6,809 |
6,278 |
$12K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
761 |
666 |
$12K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
7,324 |
5,870 |
$12K |
| 88307 |
|
808 |
735 |
$12K |
| C1769 |
Guide wire |
2,976 |
2,568 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
23,032 |
21,019 |
$11K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
97,133 |
72,718 |
$11K |
| 73502 |
|
504 |
463 |
$10K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
8,970 |
8,579 |
$10K |
| 73080 |
|
1,074 |
1,003 |
$10K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
2,804 |
2,512 |
$10K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
45,578 |
36,577 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
3,195 |
3,048 |
$9K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,183 |
798 |
$9K |
| 96376 |
|
13,187 |
8,523 |
$9K |
| 73090 |
|
1,250 |
1,141 |
$9K |
| 88304 |
|
1,481 |
1,408 |
$9K |
| 70544 |
|
45 |
38 |
$9K |
| S9083 |
Global fee urgent care centers |
543 |
486 |
$8K |
| 83690 |
|
29,980 |
26,772 |
$8K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
592 |
254 |
$7K |
| 71045 |
Radiologic examination, chest; single view |
27,772 |
24,934 |
$7K |
| 84703 |
|
24,346 |
22,318 |
$7K |
| J1756 |
Injection, iron sucrose, 1 mg |
36 |
12 |
$6K |
| 29515 |
|
40 |
37 |
$6K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
28 |
27 |
$6K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
96 |
75 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
16,229 |
13,616 |
$5K |
| 93798 |
|
81 |
12 |
$5K |
| 97166 |
|
2,030 |
1,808 |
$5K |
| C1889 |
Implantable/insertable device, not otherwise classified |
208 |
189 |
$5K |
| 82248 |
|
1,062 |
765 |
$5K |
| 81025 |
|
14,401 |
13,586 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,834 |
2,680 |
$5K |
| 81001 |
|
37,040 |
33,533 |
$5K |
| 76830 |
Ultrasound, transvaginal |
3,658 |
3,423 |
$5K |
| 84484 |
|
30,584 |
23,948 |
$5K |
| 87186 |
|
4,805 |
4,440 |
$4K |
| 97161 |
|
1,252 |
1,173 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16,360 |
12,000 |
$4K |
| 86308 |
|
572 |
551 |
$4K |
| 87040 |
|
7,225 |
5,928 |
$4K |
| 73590 |
|
1,482 |
1,302 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
177 |
172 |
$3K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
302 |
188 |
$3K |
| 74019 |
|
80 |
78 |
$3K |
| 73552 |
|
375 |
340 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
107,060 |
74,362 |
$3K |
| C1729 |
Catheter, drainage |
846 |
553 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,514 |
4,325 |
$3K |
| 90715 |
|
2,835 |
2,732 |
$2K |
| 76801 |
|
2,315 |
2,101 |
$2K |
| 97163 |
|
642 |
567 |
$2K |
| 83735 |
|
26,154 |
17,574 |
$2K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
26 |
26 |
$2K |
| 72100 |
|
326 |
300 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,935 |
9,087 |
$2K |
| 72040 |
|
88 |
78 |
$2K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,560 |
4,361 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
35,781 |
29,419 |
$2K |
| 85379 |
|
5,936 |
5,507 |
$2K |
| 83605 |
|
14,340 |
12,313 |
$2K |
| C8923 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, without spectral or color doppler echocardiography |
19 |
19 |
$2K |
| 69209 |
|
181 |
178 |
$2K |
| J1815 |
Injection, insulin, per 5 units |
7,520 |
3,654 |
$1K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
7,020 |
3,730 |
$1K |
| 83880 |
|
7,008 |
6,238 |
$1K |
| 92523 |
|
64 |
56 |
$1K |
| 85610 |
|
24,914 |
21,239 |
$1K |
| 76870 |
|
57 |
55 |
$1K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,842 |
1,428 |
$1K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
1,966 |
1,159 |
$1K |
| A9579 |
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml |
1,175 |
961 |
$1K |
| G0383 |
Level 4 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
54 |
39 |
$1K |
| 81003 |
|
25,460 |
23,705 |
$1K |
| 85730 |
|
18,701 |
16,479 |
$1K |
| 80061 |
Lipid panel |
3,696 |
3,306 |
$999.33 |
| 92610 |
|
207 |
180 |
$991.69 |
| 87634 |
|
2,109 |
2,039 |
$962.26 |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
1,712 |
1,015 |
$912.62 |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
130 |
121 |
$900.00 |
| 86141 |
|
2,979 |
2,642 |
$899.44 |
| J1644 |
Injection, heparin sodium, per 1000 units |
9,169 |
3,925 |
$882.87 |
| 76770 |
|
186 |
166 |
$875.70 |
| 82550 |
|
6,626 |
5,728 |
$825.73 |
| 82962 |
|
29,235 |
15,718 |
$798.47 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
18,774 |
16,653 |
$797.09 |
| J2060 |
Injection, lorazepam, 2 mg |
4,820 |
3,988 |
$779.13 |
| 86850 |
|
7,735 |
6,957 |
$756.04 |
| 73060 |
|
176 |
165 |
$747.29 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,670 |
3,486 |
$682.30 |
| A9270 |
Non-covered item or service |
25,987 |
9,988 |
$655.31 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
19,327 |
13,705 |
$632.83 |
| G0379 |
Direct admission of patient for hospital observation care |
74 |
68 |
$623.35 |
| 97167 |
|
484 |
417 |
$621.11 |
| 82565 |
|
2,118 |
1,961 |
$581.67 |
| 85027 |
|
10,469 |
8,460 |
$558.88 |
| 87081 |
|
48 |
40 |
$518.16 |
| 82803 |
|
1,821 |
1,637 |
$493.39 |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,398 |
1,853 |
$491.58 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
1,859 |
1,455 |
$470.05 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13,757 |
12,740 |
$456.64 |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,937 |
1,233 |
$449.90 |
| 86900 |
|
8,726 |
7,860 |
$446.92 |
| 87205 |
|
2,290 |
1,998 |
$434.94 |
| 87210 |
|
880 |
851 |
$413.70 |
| 86901 |
|
8,728 |
7,861 |
$407.81 |
| 97802 |
|
12 |
12 |
$380.65 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
2,740 |
1,968 |
$376.42 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
7,673 |
7,198 |
$375.11 |
| 85652 |
|
2,402 |
2,132 |
$345.81 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
187 |
167 |
$304.83 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
5,906 |
4,867 |
$303.95 |
| 84100 |
|
5,959 |
4,902 |
$296.02 |
| 82607 |
|
1,304 |
1,169 |
$282.05 |
| 72192 |
|
14 |
13 |
$267.50 |
| 87077 |
|
5,833 |
5,402 |
$267.31 |
| 84439 |
|
1,110 |
1,025 |
$257.21 |
| 87480 |
|
387 |
368 |
$236.39 |
| 97535 |
Self-care/home management training, each 15 minutes |
623 |
391 |
$225.35 |
| 84550 |
|
1,835 |
1,537 |
$225.27 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
4,962 |
4,512 |
$223.12 |
| 72170 |
|
989 |
903 |
$221.21 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
44 |
38 |
$210.32 |
| G0257 |
Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility |
45 |
26 |
$208.74 |
| 97165 |
|
98 |
88 |
$204.31 |
| J2704 |
Injection, propofol, 10 mg |
10,331 |
9,365 |
$201.68 |
| 82728 |
|
1,158 |
1,003 |
$196.02 |
| 99152 |
|
2,456 |
2,205 |
$186.71 |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
400 |
328 |
$183.30 |
| 82140 |
|
1,359 |
1,173 |
$182.37 |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
33 |
21 |
$181.70 |
| 86592 |
|
580 |
546 |
$176.82 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
6,666 |
6,042 |
$165.45 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
15,655 |
13,639 |
$140.80 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
7,037 |
6,182 |
$130.85 |
| 84145 |
|
2,113 |
1,855 |
$120.17 |
| 82746 |
|
1,071 |
967 |
$116.70 |
| C9113 |
Injection, pantoprazole sodium, per vial |
2,413 |
1,454 |
$115.04 |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,563 |
1,352 |
$113.01 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,533 |
2,151 |
$102.35 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
4,450 |
3,116 |
$102.28 |
| 87428 |
|
313 |
309 |
$102.26 |
| J1790 |
Injection, droperidol, up to 5 mg |
1,076 |
1,000 |
$101.10 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,725 |
1,501 |
$100.63 |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
193 |
116 |
$90.00 |
| 84466 |
|
783 |
690 |
$84.48 |
| 84156 |
|
1,843 |
1,410 |
$81.07 |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
44 |
44 |
$80.36 |
| 87420 |
|
117 |
114 |
$78.65 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
1,983 |
1,856 |
$76.86 |
| 85007 |
|
3,882 |
3,095 |
$69.06 |
| 84270 |
|
33 |
29 |
$66.81 |
| 85049 |
|
518 |
447 |
$65.54 |
| 88342 |
|
634 |
577 |
$63.61 |
| 87510 |
|
387 |
368 |
$61.92 |
| 87660 |
|
387 |
368 |
$61.82 |
| J1956 |
Injection, levofloxacin, 250 mg |
440 |
306 |
$59.54 |
| 99153 |
Mod sedat endo service >5yrs |
1,954 |
1,743 |
$55.83 |
| 83540 |
|
890 |
781 |
$51.12 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,597 |
1,461 |
$48.60 |
| 82731 |
|
221 |
202 |
$45.26 |
| 87400 |
|
757 |
705 |
$42.67 |
| 87147 |
|
415 |
387 |
$34.28 |
| 82010 |
|
753 |
687 |
$32.99 |
| 96367 |
|
294 |
226 |
$31.05 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
8,681 |
7,856 |
$29.15 |
| 85014 |
|
857 |
708 |
$29.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,726 |
2,370 |
$24.57 |
| 83615 |
|
1,736 |
1,480 |
$21.68 |
| 82570 |
|
1,841 |
1,484 |
$19.95 |
| 84132 |
|
1,407 |
1,129 |
$19.89 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
3,161 |
2,665 |
$19.21 |
| 82150 |
|
575 |
528 |
$17.68 |
| 85384 |
|
1,749 |
1,525 |
$16.60 |
| 36591 |
|
21 |
12 |
$12.71 |
| Q0114 |
Fern test |
1,027 |
971 |
$11.51 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
151 |
137 |
$11.21 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
2,919 |
2,692 |
$9.36 |
| 87340 |
|
198 |
182 |
$9.12 |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,101 |
1,936 |
$9.07 |
| J1953 |
Injection, levetiracetam, 10 mg |
482 |
378 |
$9.00 |
| 81005 |
|
693 |
640 |
$7.03 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
229 |
206 |
$6.65 |
| 85018 |
|
582 |
439 |
$1.86 |
| 85347 |
|
576 |
496 |
$1.72 |
| P9612 |
Catheterization for collection of specimen, single patient, all places of service |
434 |
405 |
$1.52 |
| 84520 |
|
1,380 |
1,286 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
2,482 |
2,211 |
$0.00 |
| G8989 |
Self care functional limitation, discharge status, at discharge from therapy or to end reporting |
242 |
219 |
$0.00 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
80 |
66 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
15 |
13 |
$0.00 |
| 87075 |
|
393 |
322 |
$0.00 |
| 87481 |
|
382 |
370 |
$0.00 |
| 89051 |
|
186 |
149 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
121 |
114 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
530 |
460 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
76 |
57 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
143 |
136 |
$0.00 |
| 82947 |
|
126 |
106 |
$0.00 |
| J0694 |
Injection, cefoxitin sodium, 1 gm |
94 |
68 |
$0.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
787 |
746 |
$0.00 |
| 90661 |
|
77 |
73 |
$0.00 |
| 85045 |
|
48 |
42 |
$0.00 |
| J2800 |
Injection, methocarbamol, up to 10 ml |
267 |
244 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
93 |
90 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
14 |
14 |
$0.00 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
83 |
67 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
529 |
459 |
$0.00 |
| 93880 |
|
14 |
14 |
$0.00 |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
79 |
68 |
$0.00 |
| 88302 |
|
12 |
12 |
$0.00 |
| 87149 |
|
22 |
13 |
$0.00 |
| 87324 |
|
14 |
13 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
19 |
12 |
$0.00 |
| 82247 |
|
19 |
12 |
$0.00 |
| Q0239 |
Injection, bamlanivimab-xxxx, 700 mg |
25 |
22 |
$0.00 |
| M0239 |
Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
24 |
22 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
23 |
13 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
327 |
298 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
544 |
332 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
1,422 |
915 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
288 |
256 |
$0.00 |
| 82553 |
|
14 |
13 |
$0.00 |
| 90686 |
|
812 |
759 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
127 |
117 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
236 |
213 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
34 |
32 |
$0.00 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
436 |
377 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
139 |
126 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
435 |
373 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
390 |
371 |
$0.00 |
| 86706 |
|
104 |
94 |
$0.00 |
| J2305 |
Injection, nitroglycerin, 5 mg |
222 |
214 |
$0.00 |
| 87449 |
|
40 |
37 |
$0.00 |
| 87493 |
|
12 |
12 |
$0.00 |
| 80051 |
|
139 |
117 |
$0.00 |
| 51798 |
|
13 |
12 |
$0.00 |
| 85576 |
|
47 |
43 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
83 |
78 |
$0.00 |
| J1836 |
Injection, metronidazole, 10 mg |
78 |
51 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
89 |
43 |
$0.00 |
| C1781 |
Mesh (implantable) |
13 |
12 |
$0.00 |
| 82945 |
|
16 |
13 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
55 |
40 |
$0.00 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
51 |
43 |
$0.00 |
| 90732 |
|
42 |
39 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
32 |
25 |
$0.00 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
13 |
13 |
$0.00 |
| S2900 |
Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) |
14 |
12 |
$0.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
14 |
12 |
$0.00 |
| 96368 |
|
24 |
24 |
$0.00 |
| J2560 |
Injection, phenobarbital sodium, up to 120 mg |
13 |
12 |
$0.00 |
| C9399 |
Unclassified drugs or biologicals |
14 |
12 |
$0.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
21 |
12 |
$0.00 |
| 84157 |
|
15 |
12 |
$0.00 |
| 88341 |
|
16 |
13 |
$0.00 |